In more recent studies, overexpression of KDM6B in transgenic mice let to a mild hematopoietic phenotype with features of MDS and CMML, including dysplasia, leukopenia, and an impaired repopulation capacity of HSPCs [62]. This evidence concerns the gene KDM6B and chronic myelomonocytic leukemia.